Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues shows that these treatments could also reduce the risk of dying from the disease in women who are at high risk.